Mild neurocognitive disorder (Q40263): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Transtorno neurocognitivo leve é caracterizado por comprometimento leve em um ou mais domínios cognitivos em relação ao esperado pela idade e nível pré-mórbido geral de funcionamento cognitivo do indivíduo, que representa um declínio do nível prévio de funcionamento do indivíduo. O diagnóstico se baseia no relato do paciente, informante, ou na observação clínica, e é acompanhado por evidência objetiva de comprometimento através de avaliação clínica quantificada ou testagem cognitiva padronizada. O comprometimento cognitivo não é grave o suficiente para interferir de forma significativa com a capacidade do indivíduo de desempenhar atividades relacionadas ao funcionamento pessoal, familiar, social, educacional e/ou ocupacional, ou outras áreas funcionais importantes. O comprometimento cognitivo não pode ser atribuído ao envelhecimento normal e pode ser estático, progressivo, ou pode se resolver ou melhorar dependendo da causa subjacente ou tratamento. O comprometimento cognitivo pode ser atribuído a uma doença subjacente adquirida no sistema nervoso, um traumatismo, uma infecção ou outro processo patológico que afetem o cérebro, uso de substâncias ou medicamentos específicos, deficiência nutricional ou exposição a toxinas, ou a etiologia pode ser indeterminada. O comprometimento não se deve a intoxicação ou abstinência atual de substância. | |||
| description / en | description / en | ||
Mild neurocognitive disorder is characterized by mild impairment in one or more cognitive domains relative to that expected given the individual’s age and general premorbid level of cognitive functioning, which represents a decline from the individual’s previous level of functioning. Diagnosis is based on report from the patient, informant, or clinical observation, and is accompanied by objective evidence of impairment by quantified clinical assessment or standardized cognitive testing. Cognitive impairment is not severe enough to significantly interfere with an individual’s ability to perform activities related to personal, family, social, educational, and/or occupational functioning or other important functional areas. Cognitive impairment is not attributable to normal aging and may be static, progressive, or may resolve or improve depending on underlying cause or treatment. Cognitive impairment may be attributable to an underlying acquired disease of the nervous system, a trauma, an infection or other disease process affecting the brain, use of specific substances or medications, nutritional deficiency or exposure to toxins, or the aetiology may be undetermined. The impairment is not due to current substance intoxication or withdrawal. | |||
Revision as of 05:59, 13 August 2026
Mild neurocognitive disorder is characterized by mild impairment in one or more cognitive domains relative to that expected given the individual’s age and general premorbid level of cognitive functioning, which represents a decline from the individual’s previous level of functioning. Diagnosis is based on report from the patient, informant, or clinical observation, and is accompanied by objective evidence of impairment by quantified clinical assessment or standardized cognitive testing. Cognitive impairment is not severe enough to significantly interfere with an individual’s ability to perform activities related to personal, family, social, educational, and/or occupational functioning or other important functional areas. Cognitive impairment is not attributable to normal aging and may be static, progressive, or may resolve or improve depending on underlying cause or treatment. Cognitive impairment may be attributable to an underlying acquired disease of the nervous system, a trauma, an infection or other disease process affecting the brain, use of specific substances or medications, nutritional deficiency or exposure to toxins, or the aetiology may be undetermined. The impairment is not due to current substance intoxication or withdrawal.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 6D71 |
||
| English | Mild neurocognitive disorder |
Mild neurocognitive disorder is characterized by mild impairment in one or more cognitive domains relative to that expected given the individual’s age and general premorbid level of cognitive functioning, which represents a decline from the individual’s previous level of functioning. Diagnosis is based on report from the patient, informant, or clinical observation, and is accompanied by objective evidence of impairment by quantified clinical assessment or standardized cognitive testing. Cognitive impairment is not severe enough to significantly interfere with an individual’s ability to perform activities related to personal, family, social, educational, and/or occupational functioning or other important functional areas. Cognitive impairment is not attributable to normal aging and may be static, progressive, or may resolve or improve depending on underlying cause or treatment. Cognitive impairment may be attributable to an underlying acquired disease of the nervous system, a trauma, an infection or other disease process affecting the brain, use of specific substances or medications, nutritional deficiency or exposure to toxins, or the aetiology may be undetermined. The impairment is not due to current substance intoxication or withdrawal. |
